| The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy L Sancey, F Lux, S Kotb, S Roux, S Dufort, A Bianchi, Y Cremillieux, ... The British journal of radiology 87 (1041), 20140134, 2014 | 243 | 2014 |
| AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine F Lux, VL Tran, E Thomas, S Dufort, F Rossetti, M Martini, C Truillet, ... The British journal of radiology 92 (1093), 20180365, 2019 | 170 | 2019 |
| Gadolinium-based nanoparticles and radiation therapy for multiple brain melanoma metastases: proof of concept before phase I trial S Kotb, A Detappe, F Lux, F Appaix, EL Barbier, VL Tran, M Plissonneau, ... Theranostics 6 (3), 418, 2016 | 162 | 2016 |
| Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol C Verry, L Sancey, S Dufort, G Le Duc, C Mendoza, F Lux, S Grand, ... BMJ open 9 (2), e023591, 2019 | 121 | 2019 |
| EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles G Bort, F Lux, S Dufort, Y Crémillieux, C Verry, O Tillement Theranostics 10 (3), 1319, 2020 | 109 | 2020 |
| Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) C Verry, S Dufort, J Villa, M Gavard, C Iriart, S Grand, J Charles, ... Radiotherapy and Oncology 160, 159-165, 2021 | 100 | 2021 |
| Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective C Verry, S Dufort, B Lemasson, S Grand, J Pietras, I Troprès, ... Science Advances 6 (29), eaay5279, 2020 | 92 | 2020 |
| MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection C Verry, S Dufort, EL Barbier, O Montigon, M Peoc'h, P Chartier, F Lux, ... Nanomedicine 11 (18), 2405-2417, 2016 | 70 | 2016 |
| Review of clinical applications of radiation-enhancing nanoparticles N Scher, S Bonvalot, C Le Tourneau, E Chajon, C Verry, J Thariat, ... Biotechnology Reports 28, e00548, 2020 | 32 | 2020 |
| Unexpected benefits of multiport synchrotron microbeam radiation therapy for brain tumors L Eling, A Bouchet, A Ocadiz, JF Adam, S Kershmiri, H Elleaume, ... Cancers 13 (5), 936, 2021 | 30 | 2021 |
| Ultrasmall theranostic gadolinium-based nanoparticles improve high-grade rat glioma survival S Dufort, G Appelboom, C Verry, EL Barbier, F Lux, E Bräuer-Krisch, ... Journal of Clinical Neuroscience 67, 215-219, 2019 | 25 | 2019 |
| Significant dose reduction using synchrotron radiation computed tomography: first clinical case and application to high resolution CT exams H Labriet, C Nemoz, M Renier, P Berkvens, T Brochard, R Cassagne, ... Scientific reports 8 (1), 12491, 2018 | 23 | 2018 |
| Toward neuro-oncologic clinical trials of high-dose-rate synchrotron microbeam radiation therapy: first treatment of a spontaneous canine brain tumor JF Adam, J Balosso, S Bayat, P Berkvens, G Berruyer, E Bräuer-Krisch, ... International Journal of Radiation Oncology* Biology* Physics 113 (5), 967-973, 2022 | 22 | 2022 |
| High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy M Bolla, C Verry, JA Long Current Opinion in Urology 23 (4), 349-354, 2013 | 21 | 2013 |
| Use of nanoparticles as radiosensitizing agents in radiotherapy: State of play C Verry, E Porcel, C Chargari, C Rodriguez-Lafrasse, J Balosso Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie …, 2019 | 16 | 2019 |
| Synchrotron stereotactic radiation therapy: A report on phase 1/2 clinical trial achievements, ongoing developments, and long-term prospects JF Adam, J Balosso, M Renier, H Elleaume, F Estève, P Berkvens, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), E624-E625, 2016 | 13 | 2016 |
| Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical … N de Leiris, J Leenhardt, B Boussat, C Montemagno, A Seiller, O Phan Sy, ... Cancer Imaging 20, 1-11, 2020 | 10 | 2020 |
| Utilisation de nanoparticules comme agent radiosensibilisant en radiothérapie: où en est-on? C Verry, E Porcel, C Chargari, C Rodriguez-Lafrasse, J Balosso Cancer/Radiothérapie 23 (8), 917-921, 2019 | 8 | 2019 |
| Pre-and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation … P Sargos, T Charleux, RL Haas, A Michot, C Llacer, L Moureau-Zabotto, ... Cancer/Radiothérapie 22 (2), 131-139, 2018 | 8 | 2018 |
| External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients N Peilleron, A Seigneurin, C Herault, C Verry, M Bolla, JJ Rambeaud, ... World Journal of Urology 39, 1489-1497, 2021 | 7 | 2021 |
